Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 10:16 am Purchase | 2023-12-31 | 13G | SYNAPTOGENIX INC SNPX | Mitchell P. Kopin | 41,929 4.990% | 10,461 (+33.24%) | Filing History |
| 2024-02-06 10:14 am Sale | 2023-12-31 | 13G | AGILE THERAPEUTICS INC PAR AGRX | Mitchell P. Kopin | 23,961 0.900% | -30,639 (-56.12%) | Filing History |
| 2024-02-06 10:12 am Unchanged | 2023-12-31 | 13G | TIAN RUIXIANG HLDGS LTD O TIRX | Mitchell P. Kopin | 10,733 8.100% | 0 (Unchanged) | Filing History |
| 2024-02-06 10:11 am Purchase | 2023-12-31 | 13G | ANTELOPE ENTERPRISE HLDGS LTD AEHL | Mitchell P. Kopin | 459 4.990% | 369 (+410.00%) | Filing History |
| 2024-02-06 10:06 am Unchanged | 2023-12-31 | 13G | ADITXT INC PAR $0.001 ADTX | Mitchell P. Kopin | 0 1.500% | 0 (Unchanged) | Filing History |
| 2024-02-06 10:04 am Unchanged | 2023-12-31 | 13G | DMK PHARMACEUTICALS CORP COM P DMKPQ | Mitchell P. Kopin | 650,000 6.000% | 0 (Unchanged) | Filing History |
| 2024-02-06 09:56 am Sale | 2023-12-31 | 13G | PHARMACYTE BIOTECH INC PMCB | Mitchell P. Kopin | 903,412 9.990% | -1,015,547 (-52.92%) | Filing History |
| 2024-02-06 09:52 am Purchase | 2023-12-31 | 13G | CLEARMIND MEDICINE INC CMND | Mitchell P. Kopin | 2,223 4.990% | 1,902 (+592.52%) | Filing History |
| 2024-02-02 4:10 pm Purchase | 2024-01-25 | 13G | REDHILL BIOPHARMA LTD RDHL | Mitchell P. Kopin | 50,000 4.000% | 50,000 (New Position) | Filing History |
| 2023-11-27 06:10 am Purchase | 2023-11-16 | 13G | BONE BIOLOGICS CORP COM 20 BBLG | Mitchell P. Kopin | 4,676 4.990% | 4,676 (New Position) | Filing History |
| 2023-08-11 4:18 pm Purchase | 2023-08-04 | 13G | NAYA BIOSCIENCES, INC. NAYA | Mitchell P. Kopin | 15,333 7.100% | 15,333 (New Position) | Filing History |
| 2023-08-10 4:03 pm Purchase | 2023-08-01 | 13G | DMK PHARMACEUTICALS CORP COM P DMKPQ | Mitchell P. Kopin | 650,000 7.600% | 650,000 (New Position) | Filing History |
| 2023-07-14 5:27 pm Purchase | 2023-07-06 | 13G | ALLARITY THERAPEUTICS INC ALLR | Mitchell P. Kopin | 75 4.990% | 58 (+341.18%) | Filing History |
| 2023-06-30 4:10 pm Purchase | 2023-06-22 | 13G | INNOVATIVE EYEWEAR INC LUCY | Mitchell P. Kopin | 28,470 4.200% | 28,470 (New Position) | Filing History |
| 2023-06-01 5:23 pm Purchase | 2023-05-23 | 13G | DERMATA THERAPEUTICS INC N DRMA | Mitchell P. Kopin | 960 4.990% | 960 (New Position) | Filing History |
| 2023-05-25 4:13 pm Sale | 2023-05-16 | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Mitchell P. Kopin | 313,158 4.990% | -1,242,404 (-79.87%) | Filing History |
| 2023-04-28 4:31 pm Purchase | 2023-04-19 | 13G | ALLARITY THERAPEUTICS INC ALLR | Mitchell P. Kopin | 17 4.200% | 17 (New Position) | Filing History |
| 2023-04-19 5:14 pm Sale | 2023-04-10 | 13G | SENESTECH INC PAR $0.001 SNES | Mitchell P. Kopin | 1,284 4.990% | -1,210 (-48.52%) | Filing History |
| 2023-04-14 4:24 pm Purchase | 2023-04-06 | 13G | CLEARMIND MEDICINE INC CMND | Mitchell P. Kopin | 321 6.300% | 321 (New Position) | Filing History |
| 2023-02-24 4:27 pm Unchanged | 2023-02-15 | 13G | ATLIS MTR VEHS INC AMV | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |